药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Pargyline
The risk or severity of hypertension can be increased when Pargyline is combined with Mirabegron.
Pirbuterol
Phendimetrazine
The risk or severity of hypertension can be increased when Phendimetrazine is combined with Mirabegron.
Pirbuterol
Chlorphentermine
The risk or severity of hypertension can be increased when Chlorphentermine is combined with Mirabegron.
Pirbuterol
Tenamfetamine
The risk or severity of hypertension can be increased when Tenamfetamine is combined with Mirabegron.
Pirbuterol
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Mirabegron.
Pirbuterol
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Mirabegron.
Pirbuterol
MMDA
The risk or severity of hypertension can be increased when MMDA is combined with Mirabegron.
Pirbuterol
Clenbuterol
The risk or severity of hypertension can be increased when Clenbuterol is combined with Mirabegron.
Pirbuterol
Procaterol
The risk or severity of hypertension can be increased when Procaterol is combined with Mirabegron.
Pirbuterol
Mephentermine
The risk or severity of hypertension can be increased when Mephentermine is combined with Mirabegron.
Pirbuterol
Ephedra sinica root
The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Mirabegron.
Pirbuterol
Pirbuterol
The risk or severity of hypertension can be increased when Pirbuterol is combined with Mirabegron.
Pirbuterol
Chlorphenoxamine
The risk or severity of urinary retention can be increased when Chlorphenoxamine is combined with Mirabegron.
Pirbuterol
Timepidium
The risk or severity of urinary retention can be increased when Timepidium is combined with Mirabegron.
Pirbuterol
Pipenzolate
The risk or severity of urinary retention can be increased when Pipenzolate is combined with Mirabegron.
Pirbuterol
Emetonium iodide
The risk or severity of urinary retention can be increased when Emetonium iodide is combined with Mirabegron.
Pirbuterol
Fenpiverinium
The risk or severity of urinary retention can be increased when Fenpiverinium is combined with Mirabegron.
Pirbuterol
Camylofin
The risk or severity of urinary retention can be increased when Camylofin is combined with Mirabegron.
Pirbuterol
Diphemanil
The risk or severity of urinary retention can be increased when Diphemanil is combined with Mirabegron.
Pirbuterol
Penthienate
The risk or severity of urinary retention can be increased when Penthienate is combined with Mirabegron.